Skip to content

Comparison the effectiveness of burn drugs on controlling pain of burn patients

Comparison the effect of Gabapentin, Ketamine, Entonox and Dexmedetomidine drugs in controlling pain of burn patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201605171310N10
Enrollment
100
Registered
2016-10-13
Start date
2016-10-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn. Burn and corrosion

Interventions

Intervention 1: The first intervention group will receive 1800 mg Gabapentin orally 2 hours before entering the operating room. Intervention 2: In the second intervention group ketamine in the form o
Treatment - Drugs
The first intervention group will receive 1800 mg Gabapentin orally 2 hours before entering the operating room.
In the second intervention group ketamine in the form of intravenous in amount of 0.1 to 0.5 mg per kg of body weight will be given one minute before the start of surgery.
The third intervention group will receive Dexmedetomidine drug in the form of intravenous infusionand 0.1 to 0.5 mg per kilogram of body weight per minute in ten minutes before the start of surgery
In the fourth intervention group five minutes before the start of surgery,Nitrous Oxide mixed with70% oxygen through a face mask is prescribed.

Sponsors

Vice chancellor for research, Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 18 and 60 years; Burn with grade 2 and 3, burns 20 percent to 50 percent; AS A Class 1 and 2 Exclusion criteria: pregnant women; People with any known chronic mental illness; Patients with history of chronic underlying cardiac, lung and kidney disease; patients treated with certain medications such as immunosuppressive medications or chemotherapy or Corticosteroid

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The amount of pain. Timepoint: Beginning of the study, half an hour, an hour, two hours, four hours, six hours after start of surgery. Method of measurement: Using visual analogue scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimin Chaghazardi

Kermanshah University of Medical Sciences

siminchaghazardi@gmail.com+98 83 3727 9104

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026